Clinical Utility of the Meal Tolerance Test in the Care of Patients with Type 2 Diabetes Mellitus-Reference-Cited by-同舟云学术

Clinical Utility of the Meal Tolerance Test in the Care of Patients with Type 2 Diabetes Mellitus

Published:2020-09-15 Issue:18 Volume:59 Page:2229-2235
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Wakasaki Hisao¹,Shono Takeshi¹,Nakao Ryutaro¹,Yamamoto Shohei¹,Minaga Takamasa¹,Fukuda Sakiko¹,Matsumoto Reika¹,Ohoshi Takashi¹,Naka Keigo¹,Nanjo Kishio¹

Affiliation:

1. Department of Internal Medicine, Wakayama Rosai Hospital, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/59/18/59_4591-20/_pdf

Reference16 articles.

1. 1. Jones AG, Hattersley AT. The clinical utility of C-peptide measurement in the care of patients with diabetes. Diabet Med 30: 803-817, 2013.

2. 2. Greenbaum CJ, Mandrup-Poulsen T, McGee PF, et al.; Type 1 Diabetes Trial Net Research Group, European C-Peptide Trial Study Group. Mixed-meal tolerance test versus glucagon stimulation test for the assessment of beta-cell function in therapeutic trials in type1 diabetes. Diabetes Care 31: 1966-1971, 2008.

3. 3. Fujioka Y, Okura T, Sumi K, et al. Normal meal tolerance test is preferable to the glucagon stimulation test in patients with type2 diabetes that are not in a hyperglycemicstate: comparison with the change of C-peptide immunoreactivity. J Diabetes Investig 9: 274-278, 2018.

4. 4. Kanda Y. Investigation of the freely-available easy-to-use software "EZR" (Easy R) for medical statistics. Bone Marrow Transplant 48: 452-458, 2013.

5. 5. Brouns F, Bjorck I, Frayn KN, et al. Glycaemic index methodology. Nutr Res Rev 18: 145-171, 2005.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. C‐peptide index at 2 h post‐meal is a useful predictor of endogenous insulin secretory capacity and withdrawal from insulin therapy in subjects with type 2 diabetes;Diabetes, Obesity and Metabolism;2024-04-22

2. Processing Alaska Pollock Protein (Theragra chalcogramma) into Kamaboko Protein Mitigates Elevated Serum Cholesterol and Postprandial Glucose Levels in Obese Zucker fa/fa Rats;Foods;2022-10-29